Durnian J M, Clearkin L G
St Pauls Eye Unit, Royal Liverpool University, Liverpool, UK.
Eye (Lond). 2008 Apr;22(4):559-63. doi: 10.1038/sj.eye.6702794. Epub 2007 Mar 30.
To describe the retinal nerve fibre layer (RNFL) characteristics in patients suffering vigabatrin-associated visual field loss or behaviour consistent with field loss.
Eight patients with visual field loss attributed to vigabatrin use had their RNFL evaluated by scanning laser polarimetry.
All eight patients managed to perform the test reliably. The mean length of vigabatrin treatment was 81 months with a mean cumulative dose of vigabatrin being 5.4 kg. All patients had significantly reduced RNFL parameters; mean TSNIT=36.5 microm, mean nerve fibre indicator=63.1, mean superior average=42.7 microm, and mean inferior average=39.2 microm. There was no correlation between cumulative dose or time on treatment and RNFL thickness.
Scanning laser polarimetry can be performed safely and reliably on patients with vigabatrin-associated field loss. RNFL thickness is reduced in these patients with vigabatrin-associated field loss. RNFL loss concentrates on the long nerve fibres, which explains the nasal pattern of field loss seen in these patients. This investigation shows promise in the screening of vigabatrin patients, especially in those patients that may not tolerate formal field testing well.
描述服用vigabatrin相关视野缺损或有与视野缺损相符行为的患者的视网膜神经纤维层(RNFL)特征。
8例因使用vigabatrin导致视野缺损的患者通过扫描激光偏振仪评估其RNFL。
所有8例患者均能可靠地完成检查。vigabatrin治疗的平均时长为81个月,vigabatrin的平均累积剂量为5.4千克。所有患者的RNFL参数均显著降低;平均TSNIT = 36.5微米,平均神经纤维指标 = 63.1,平均上方平均值 = 42.7微米,平均下方平均值 = 39.2微米。累积剂量或治疗时间与RNFL厚度之间无相关性。
扫描激光偏振仪可安全、可靠地用于vigabatrin相关视野缺损患者。这些vigabatrin相关视野缺损患者的RNFL厚度降低。RNFL损失集中在长神经纤维上,这解释了这些患者中所见的鼻侧视野缺损模式。本研究在vigabatrin患者筛查中显示出前景,尤其是在那些可能无法很好耐受正规视野检查的患者中。